Not a healthcare professional? Visit our Public site
For UK Healthcare Professionals
This site may contain promotional material
Report adverse event
User logged in
Summary of product characteristics
Patient information leaflet
Default Page URL : http://public.gsk.co.uk
Corresponding Page URL : Corresponding URL
This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.
Request a contact
Toctino is indicated for use in adults who have severe chronic hand eczema that is unresponsive to treatment with potent topical corticosteroids.
How to prescribe Toctino and clinical data
Download Pregnancy Prevention Programme information to support your patients
Latest European guidelines on hand eczema
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.
Toctino is a registered trademark of Stiefel Laboratories, Inc.
A.M. 10 February 2016. UK/ART/0017/13(2)
Get in touch
To discuss our products, supply, educational events or any other information
©2016 GlaxoSmithKline group of companies. All rights reserved. GlaxoSmithKline UK Limited Registered in England and Wales No 4310159.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.
M.C. Last updated 07 December 2015. UK/COM/0106/15(1).
This browser is not supported and will result in the website not being optimally presented. You are recommended to use an alternate browser such as Chrome, Opera or FireFox